¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"lead neuropathy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • paraneoplastic neuropathy
    ½Å»ý¹°µþ¸²½Å°æº´(Áõ)
  • peripheral neuropathy
    ¸»ÃʽŰ溴(Áõ)
  • bipolar lead
    µÎ±ØÀ¯µµ, ½Ö±ØÀ¯µµ
  • black lead
    Èæ¿¬
  • electrocardiogram lead
    ½ÉÀüµµÀ¯µµ
  • endocardial lead
    ½É³»¸·À¯µµ, ½ÉÀå¼Ó¸·À¯µµ
  • epicardial lead
    ½É¿Ü¸·À¯µµ, ½ÉÀå¹Ù±ù¸·À¯µµ
  • esophageal lead
    ½ÄµµÀ¯µµ
  • lead
    1. ³³ 2. µµÃâ, À¯µµ 3. Àü±Ø
  • lead acetate
    Ãʻ곳
  • lead colic
    ³³±ÞÅëÁõ
  • lead encephalopathy
    ³³Áßµ¶³úº´(Áõ)
  • lead gout
    ³³Åëdz
  • lead line
    ³³¼±
  • lead neuritis
    ³³Áßµ¶½Å°æº´Áõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • black lead
    Èæ¿¬
  • lead-time bias
    Á¶±â¹ß°ß±â°£¹ÙÀ̾
  • lead colic
    ³³±ÞÅëÁõ
  • electrocardiogram lead
    ½ÉÀüµµÀ¯µµ
  • endocardial lead
    ½É³»¸·À¯µµ
  • epicardial lead
    ½ÉÀå¿Ü¸·À¯µµ
  • esophageal lead
    ½ÄµµÀ¯µµ
  • lead pipe fracture
    ³³ÆÄÀÌÇÁ°ñÀý, ¿¬°ü»ó°ñÀý
  • lead gout
    ³³Åëdz
  • lead
    ³³, µµÃâ, À¯µµ
  • lead acetate
    Ãʻ곳
  • lead nitrate
    Áú»ê³³
  • lead line
    ³³¼±
  • lead neuritis
    (¢¡lead neuropathy) ³³Áßµ¶½Å°æº´Áõ
  • lead poisoning
    ³³Áßµ¶
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • neuropathy
    ½Å°æº´Áõ(¡­Ü»ñø)
  • neuropathy
    ½Å°æº´Áõ
  • neuropathy,amyloidotic
    ¾Æ¹Ð·ÎÀ̵强(¡­àõ)
  • neuropathy,compression
    ¾Ð¹Ú¼º(äâÚÞàõ)
  • neuropathy,entrapment
    Æ÷Âø¼º(øÚóµàõ)
  • neuropathy,paraneoplastic
    ¹æÁ¾¾ç¼º(Û·ðþåËàõ)
  • optic neuropathy
    ½Ã½Å°æº´Áõ
  • optic neuropathy
    ½Ã½Å°æº´Áõ(ãÊãêÌèÜ»ñø)
  • peripheral neuropathy
    ¸»ÃʽŰ溴Áõ.
  • peripheral neuropathy
    ¸»ÃʽŰ溴Áõ(ØÇôþãêÌèÜ»ñø)
  • peripheral neuropathy,diphtheritic
    µðÇÁÅ׸®¾Æ¼º(¡­àõ)
  • posterior ischemic optic neuropathy
    ÈÄÇãÇ÷½Ã½Å°æº´Áõ
  • retrobulbar neuropathy
    ±¸ÈĽýŰ溴Áõ(Ϲý­ãÊãêÌèÜ»ñø)
  • subacute myelo optico neuropathy
    ¾Æ±Þ¼º ô¼ö½Ã½Å°æÀå¾Ö(¡­ô±âÐãÊãêÌèî¡äô)
  • subacute myelo-optic neuropathy
    ¾Æ±Þ¼ºÃ´¼ö½Ã½Å°æº´Áõ(¡­ô±âÐãÊãêÌèî¡äô ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CF calcaneal fibular [ligament]; calcium leucovorin; calf blood flow; calibration factor; cancer-free; ...
CL capillary lumen; cardiolipin; cell line; centralis lateralis; chemiluminescence; chest and left arm ...
CR calculation rate; calculus removed; calorie-restricted; cardiac rehabilitation; cardiac resuscitatio...
LTAS lead tetra-acetate Schiff
MCL maximum containment laboratory; medial collateral ligament; midclavicular line; midcostal line; mini...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
AION Anterior Ischemic Optic Neuropathy
AN Autonomic neuropathy
CAN Cardiac autonomic neuropathy
CAN Cardiovascular autonomic neuropathy
CIDP Chronic Inflammatory Demyelinating Neuropathy
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • lead equivalent
    ¿¬ ´ç·®
    ¹æ»ç¼± Â÷Æó¿¡ À־ ¾î¶² ¹°ÁúÀÇ Â÷Æó È¿°ú¸¦ ±×¿Í ºñ½ÁÇÑ È¿°ú¸¦ ³ªÅ¸³»´Â ³³ÀÇ µÎ²²·Î Ç¥ÇöÇÑ °Í.
  • lead glass
    ³³ À¯¸®
    X¼± ÃÔ¿µ ½Ã 1Â÷¼±À̳ª 2Â÷¼±À¸·ÎºÎÅÍ º¸È£¹Þ±â À§ÇÏ¿© ¹æ¾î¸· ¶Ç´Â ¹æ¾îº®ÀÇ Ã¢¹®¿¡ ÀåÄ¡ÇÏ´Â À¯¸®·Î, ±× ¾È¿¡ ³³ÀÌ µé¾î ÀÖ´Â °Í.
  • lead gray
    ³³ ȸ»ö
  • lead line
    ¿¬¼±
    ³³ÀÌ ´Ù¸¥ ±Ý¼Ó ȤÀº °°Àº ³²°ú ÁßÇÕµÇ¾î »ý±ä ¼±.
  • lead neuritis
    ¿¬ ½Å°æ¿°
  • lead nitrate
    Áú»ê ³³
  • lead oleate ointment
    ´Ü¿¬ ¿¬°í
  • lead orthoplumbate
    ¿À¸£Åä³³»ê ³³
  • lead paper
    ¿¬´çÁö
  • lead pencil stool
    ¿¬ÇÊ ¸ð¾çÀÇ º¯
  • lead pipe fracture
    ¿¬°ü»ó °ñÀý
  • lead plaster
    ´Ü¿¬ °æ°í
  • lead resinate
    ¼öÁö»ê ³³
  • lead seam
    ¿¬¿¬
    ³³ÀÌ ´Ù¸¥ ±Ý¼Ó ȤÀº °°Àº ³³°ú ÁßÇÕµÈ ÈçÀû.
  • lead sugar
    ¿¬´ç
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
neuropathy <clinical sign> A general term denoting functional disturbances and/or pathological changes in the peripheral nervous system. If the involvement is in one nerve it is called mononeuropathy, in several nerves, mononeuropathy multiplex, if diffuse and bilateral, polyneuropathy.
The aetiology may be known for example arsenical neuropathy, diabetic neuropathy, ischaemic neuropathy, traumatic neuropathy) or unknown. Encephalopathy and myelopathy are corresponding terms relating to involvement of the brain and spinal cord, respectively. The term is also used to designate noninflammatory lesions in the peripheral nervous system, in contrast to inflammatory lesions (neuritis).
Origin: Gr. Pathos = disease
(18 Nov 1997)
dapsone neuropathy A peripheral neuropathy that develops in patients taking dapsone (4,4-diaminodiphenylsulfone); unusual features include being a pure motor neuropathy, and beginning in the hands, sometimes asymmetrically.
(05 Mar 2000)
symmetric distal neuropathy <neurology> A disease process involving a number of peripheral nerves.
Origin: Gr. Pathos = disease
(14 Oct 1997)
diabetic neuropathy <neurology, pathology> Long standing or poorly controlled diabetes can cause permanent peripheral and autonomic nerve dysfunction known as diabetic neuropathy.
Origin: Gr. Pathos = disease
(27 Sep 1997)
diphtheritic neuropathy A rapidly developing peripheral neuropathy caused by a toxin elaborated by Corynebacterium diphtheriae.
(05 Mar 2000)
ischemic neuropathy Neuropathy resulting from acute or chronic ischemia of the involved nerves.
(05 Mar 2000)
ischemic optic neuropathy Optic nerve neuropathy secondary to hypoperfusion of the low pressure posterior ciliary arteries supplying the optic nerve head (nonarteritic) or to temporal arteritis (arteritic).
(05 Mar 2000)
isoniazid neuropathy An axonal form of neuropathy seen in some patients treated with isoniazid.
(05 Mar 2000)
onion bulb neuropathy Designation for any of several demyelinating polyneuropathies in which the nerves are enlarged, due to onion bulb formation-whorls of overlapping Schwann cell processes encircling bare medullated axons, e.g., progressive hypertrophic polyneuropathy.
See: hypertrophic interstitial neuropathy.
(05 Mar 2000)
optic neuropathy, ischemic A severely blinding disease resulting from loss of the arterial blood supply to the optic nerve as a result of occlusive disorders of the nutrient arteries. Optic neuropathy is divided into anterior, which causes a pale oedema of the optic disk, and posterior, in which the optic disk is not swollen and the abnormality occurs between the globe and the optic chiasm. Ischemic anterior optic neuropathy usually causes a loss of vision that may be sudden or occur over several days; ischemic posterior optic neuropathy is uncommon and the diagnosis depends largely upon exclusion of other causes, chiefly stroke and brain tumour.
(12 Dec 1998)
entrapment neuropathy A focal nerve lesion produced by constriction or mechanical distortion of the nerve, within a fibrous or fibro-osseous tunnel, or by a fibrous band; with these lesions, stretching and angulation of the nerve may be as important a source of injury as compression; entrapment neuropathies tend to occur at particular sites in the body.
(05 Mar 2000)
familial amyloid neuropathy <neurology> A disorder in which various peripheral nerves are infiltrated with amyloid and their functions disturbed, an abnormal prealbumin is also formed and is present in the blood; characteristically, it begins during mid-life and is found largely in persons of Portuguese descent. Other rare clinical types occur.
Inheritance: autosomal dominant.
Synonym: familial amyloidosis, hereditary amyloidosis.
(05 Mar 2000)
leprous neuropathy A slowly developing granulomatous neuropathy, commonly seen in leprosy, caused by Mycobacterium leprae.
(05 Mar 2000)
augmented lead Electrocardiogram recorded between one limb and two other limbs. The augmented lead are designated aVF, aVL, and aVR for recordings made between the foot (left), left arm, and right arm, respectively, and the other two limbs.
(05 Mar 2000)
bipolar lead A record obtained with two electrodes placed on different regions of the body, each electrode contributing significantly to the record; e.g., a standard limb lead.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • lead poisoning
    ¿¬µ¶;³³Áßµ¶
  • lead swinger
    ²ÒÀïÀÌ;°ÔÀ¸¸§¹ðÀÌ(Ãø¿¬ ÀÛ¾÷À» Çϴ üÇÏ´Â)
  • lead time
    ±âȹ¿¡¼­ »ý»ê±îÁöÀÇ ½Ã°£;¹ßÁÖ¿¡¼­ ¹è´Þ±îÁöÀÇ ½Ã°£;¹ßÁÖ¿¡¼­ ¹è´Þ±îÁöÀÇ ½Ã°£
  • lead wool
    ¿¬¸ð(ÆÄÀÌÇÁ Á¢ÇÕ¿ë)
  • pot lead
    Èæ¿¬
  • red lead
    ¿¬´Ü;±¤¸í´Ü(»êÈ­³³À¸·Î ¸¸µç ¹°°¨)
  • red-lead
    ¿¬´Ü(±¤¸í´Ü)À» ¹Ù¸£´Ù
  • sounding lead
    Ãø¿¬
  • tetraethyl lead
    Åׯ®¶ó¿¡Æ¿¿¬;4¿¡Æ¿¿¬
  • white lead
    ¹é¿¬
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á